ONiP Logo

Optimising Care for Patients with Acute Myeloid Leukaemia


This module has been designed to provide you with an understanding of acute myeloid leukaemia (AML) including its subtypes, the methods used in disease diagnosis and management, considerations associated with AML treatment, as well as its impact on a patient’s quality of life. This module also describes the key role nurses play in managing patients with AML and methods for supporting those patients and their families through their journey.

The module will provide you with useful tools and resources to help support your AML patients at the different stages of the disease.

Please see our disclaimer regarding module content.


This e-learning module will take 60 minutes to complete, although this will depend on your level of knowledge.  Optional pre-reading, available in the ‘resources’ section of this page, will take approximately 30–60 minutes. Saving where you left off, you can dip in and out of the module whenever you have the time. You are encouraged to make notes or take screenshots during the module to reinforce your learning.


A certificate is still available to download upon module completion to add to your portfolio, however accreditation received by the Federation of the Royal College of Nursing (RCN) has expired.

Nurses play a key role in the provision of care to patients who have been diagnosed with acute myeloid leukaemia, supporting them through their various treatment therapies.

CPD Module

This module has been developed to provide nurses with knowledge of best practices for the optimal management of patients with AML.

Optimising Care for Patients with Acute Myeloid Leukaemia


* Save your place and obtain CME credits.

† Your place will not be saved.


The faculty

Jacqueline Wilson

Senior Sister of the Day Case Chemotherapy Unit and Community Chemotherapy Service, Birmingham Heartlands Hospital.

Matt Fowler

Consultant Nurse for Oncology and Haematology, Heartlands Hospital, Birmingham, UK

This independent educational activity is supported by an educational grant provided by Jazz Pharmaceuticals. PCM Scientific is the medical education company acting as scientific secretariat and organiser for this programme. The activity is run independently of the financial supporter and all content is created by the faculty. No funder has had input into the content of the activity.